All posts by imreal

Health: Mental Health

ProPharma Appoints Alena Hammond as Global Head of Clinical Operations

Leave a comment


“I am excited to join ProPharma and lead the Clinical Operations team,” said Alena Hammond. “ProPharma has a strong reputation for excellence in the industry, and I look forward to contributing to the company’s continued growth and success.”

Kevin Wysocki, President of Clinical Research Solutions at ProPharma, commented: “We are delighted to welcome Alena Hammond to ProPharma. Her extensive experience and proven track record in clinical operations will be instrumental in strengthening our capabilities and expanding our global reach. Alena’s leadership will be invaluable as we continue to support our clients in their critical clinical trial endeavors.”

Alena Hammond’s appointment marks another milestone for ProPharma as the company continues to advance its position as a leader in clinical research solutions. With her leadership, ProPharma will continue to meet the evolving needs of clients and the pharmaceutical, biotech, and medical device sectors.

About ProPharma
For over 20 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. As the world’s largest RCO (Research Consulting Organization), ProPharma partners with its clients through an advise-build-operate model across the complete product lifecycle. With deep domain expertise in regulatory sciences, clinical research solutions, quality and compliance, pharmacovigilance, medical information, and R&D technology, ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate our partners’ most high-profile drug and device programs.

For more information about ProPharma, please visit: https://www.propharmagroup.com.

Media Inquiries and Contacts:

Zosya Popik
Vice President, Global Marketing
ProPharma
[email protected]

Jason Wakeford
Associate Partner
Clarity for ProPharma
[email protected]

Media Contact

Jason Wakeford, Clarity for ProPharma, 424-385-4062, [email protected], https://www.propharmagroup.com/

SOURCE Clarity for ProPharma

Science: Biology

Harnessing Real-time Employee Insights for Proactive Business Decision-Making

Leave a comment


“Every business leader knows the value of timely, reliable insights. Our unique approach centers on gathering real-time data from those who know your operations best: your employees,” said Tammy Savage, Groopit co-founder and CEO. “With Groopit AI, you won’t just gather data; you’ll distill actionable, forward-looking intelligence, enabling leaders to act swiftly and confidently.”

Groopit’s emphasis on high provenance data sets it apart. By collecting insights from employees – those immersed in the intricacies of their roles and industry nuances – Groopit guarantees data of the highest caliber. High-quality human intelligence is then analyzed by Groopit’s advanced AI capabilities, meticulously extracting patterns, anomalies, and highlights. The result is an actionable insight feed tailored for each organization.

Rick McInturff, Walmart Customer Team Lead at UTZ Brands, shared his experience: “Groopit has revolutionized how we gather insights from the field and use them to make decisions. With insights directly from our teams on the ground, combined with powerful Groopit AI, we’re not just reacting; we’re strategically managing our next moves.”

Key features of Groopit AI include:

  • Employee-sourced intelligence: Groopit utilizes high-provenance data from informed employees to form the basis for high-quality decision making.
  • Advanced AI analysis: Groopit analyzes human intelligence to understand context, extract key insights, and identify themes and statistical patterns, then generates summary insights written in natural language.
  • Summary insight publishing: Groopit makes it easy for leaders to publish the actionable insights generated by AI to the employees who are involved, interested, and contributing intel.
  • Existing systems integration: Groopit allows data from existing systems, like Salesforce, to be incorporated into the human intelligence that is analyzed, allowing historical context to be included.
  • Knowledge base building: Groopit automatically builds a robust and accessible set of employee insights that grows into a well-organized and valuable corporate asset over time.

Groopit AI is a continuation of Groopit’s commitment to innovative solutions that empower leaders. Groopit AI is not just a tool; it’s a paradigm shift in business intelligence.

About Groopit

Groopit is the leading provider of crowdsolving software, a new category of enterprise SaaS software that transforms how people come together to solve problems. With Groopit, front-line employees share real-time data to illuminate a problem, and everyone involved is empowered to make better, faster decisions. To learn more about Groopit, visit https://groopit.co/.

Media Contact

Media Relations, Groopit, Inc, 1 5643334340, [email protected], https://groopit.co

Twitter, LinkedIn

SOURCE Groopit, Inc



Science: Biology

Quintus Cold Isostatic Press to Join World-Class Equipment Lineup at China’s Lingchuang Special Material Co.

Leave a comment


World’s Largest CIP Will Boost High-Quality Domestic Graphite Supply for Growing Solar, Electronics, and Metallurgical Markets

VÄSTERÅS, Sweden, Sept. 27, 2023 /PRNewswire-PRWeb/ — A supersized Cold Isostatic Press (CIP) from Quintus Technologies will be instrumental in the quest by China’s Henan Lingchuang Special Material Co. to raise the bar for domestically produced high-quality Isostatic Graphite.

With its sights set on securing a place as market leader in both product quality and production efficiency, Lingchuang will install a Quintus press model QIC 2.4 x 4.5 – 2000 to maximize operation and output capabilities. The press itself is setting new standards, with its world’s-largest vessel dimension—2400 mm x 4500 mm (7.87′ x 14.7′)—along with a new energy management system that offers energy savings of more than 30 percent compared to conventional intensifier solutions.

“Lingchuang is committed to building itself into a domestic first-class special carbon material production enterprise,” notes the company’s Vice President, Zhongxin Zhao, adding that the Quintus press is part of its key equipment.

“In order to ensure the stability and consistency of product quality that reaches the international level, we have adopted the most advanced technology that has been proved in production at home and abroad,” Mr. Zhongxin Zhao continues. “Our key equipment is mainly imported, and the production process has reached a high degree of automation, stability, and environmental protection.”

Quintus Cold Isostatic Presses offer the safest, most durable, and reliable pressure containment system ever designed. Subsystem components are optimized for maximum throughput and precise control of pressurization and depressurization for consistent results. Lingchuang’s CIP will be equipped with a new, first-of-its-kind feature: a redesigned pressure vessel that is fully floating during pressurizing, extending the life of the guide rail system and ensuring maintenance-free operation over a very long period of time.

“Coming from the pioneer of wire-winding technology, Quintus equipment has a high reputation in the global industry,” says Mr. Zhongxin Zhao. “We believe that it will well meet our requirements for high-end isostatic graphite production.”

Lingchuang has also elected to participate in a long-term Quintus® Care Program, a rigorous agreement that ensures flawless press operation and equipment maintenance. The program provides for application support, high availability of spare and wear parts, and guaranteed and prioritized technical support. It also includes annual press inspections, training, and recertification of Lingchuang personnel to maintain and elevate their skills.

“Lingchuang is a young company with a far-ranging outlook,” comments Jan Söderström, CEO of Quintus Technologies. “Its founders saw opportunity in the shortage of domestic high-end specialty graphite materials, and they are investing astutely in world-class equipment to take a leading position in that space. We are very pleased to be part of their plan,” he concludes.

About Quintus Technologies

Quintus Technologies is the global leader in high pressure technology. The company designs, manufactures, installs, and supports high pressure systems in three principal areas: densification of advanced materials; sheet metal forming; and high pressure processing for food and beverage innovation, safety, and shelf life. Quintus has delivered over 1,900 systems to customers within industries such as energy, medical implants, space, aerospace, automotive, and food processing. The company is headquartered in Västerås, Sweden, with a presence in 45 countries worldwide. For more information, visit www.quintustechnologies.com

About Lingchuang

Henan Lingchuang Special Material Co., Ltd. was established in July 2019 to focus on the production of specialty graphite to meet the rigorous quality demands of high-tech manufacturing sectors such as the solar and photovoltaic, semiconductor materials, hydrogen energy, chemical, and metallurgy industries. Located in Henan Province in the east-central region of China, the company’s facility covers an area of approximately 600 mu [400,000 m2 or 4.3 million sf] and has a total production capacity of 50,000 tons of special graphite products annually. Lingchuang is part of a group of companies under the ownership of the Zhang family, which is also active in the Chinese cement industry, and in construction and real estate both domestically and in the U.S. Go to www.lcdcchina.com for more.

Media Contact

Peter Henning, Quintus Technologies, 46 73 620 24 49, [email protected], www.quintustechnologies.com

SOURCE Quintus Technologies

Health

Cytovance Biologics Announces Dr. Axel Schleyer to Expand Footprint and Service Offering as Chief Commercial Officer

Leave a comment


Dr. Schleyer joins the team most recently from Stelis BioPharma, where he served as SVP of Business Development after his tenure as President and CEO of Aragen Bioscience. He has held leadership roles of increasing responsibility at AGC Biologics, Boehringer Ingelheim, Baxter Healthcare, and Lonza, where he supported international activities in the United States, Germany, China, Japan, and Switzerland. Dr. Schleyer is a doctoral graduate of the University of Hamburg and carried out his postdoctoral studies at the Scripps Research Institute, known for influential bioscience innovations. Additionally, he holds an MBA from California State University.

“Cytovance Biologics is a very special CDMO, with a history deeply rooted in successful novel drug development and a team that I believe is uniquely positioned to deliver both scientific rigor and extreme ingenuity in the face of complex customer needs,” shared Dr. Schleyer. “As both Team Cytovance and individuals, my colleagues share an infectious energy and passion for problem-solving that I find inspiring. I have enjoyed my time in Oklahoma City meeting the team, exploring our facilities, and assessing opportunities to grow our CGMP manufacturing capacity. And I look forward to leveraging my experience to grow our industry footprint by sharing how a responsive, reliable, and resourceful CDMO partner can make a world of difference on the path from molecule to market.”

Dr. Schleyer will represent Cytovance at CPHI in Barcelona this October. If you are interested in scheduling a meeting, please visit https://info.cytovance.com/en-us/cphi2023.

About Cytovance Biologics:

Cytovance® Biologics is a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) offering ingenuity and integrated development services to support large molecule biologics throughout the journey from R&D to regulatory approval. These services include mammalian cell line development, cell banking, microbial strain development, process and analytical development, process characterization, and CGMP manufacturing. The company’s 140,000+ sq. ft. state-of-the-art facilities in America’s Heartland are designed to meet US, EU, and global regulatory requirements.

Find out more at https://cytovance.com/.

Media Contact

Savannah Worcester, on Behalf of Cytovance Biologics, 1 615-719-1110, [email protected]

SOURCE Cytovance Biologics

Health: Psychology

Boulder Crest Foundation Receives Honors from AARP and Governor of Virginia

Leave a comment


First Lady Suzanne S. Youngkin and Governor Glenn Youngkin presented the Spirit of Virginia Award at Boulder Crest’s 10th anniversary celebration on September 8. The prestigious honor recognizes pioneers across the Commonwealth for their outstanding achievements and extraordinary contributions in a variety of categories, including education, culture, the arts, and philanthropy.

“After watching my fellow veterans return home from combat, my wife and I started bringing wounded warriors to our home and ultimately donated 37 acres of our estate to build the nation’s first-ever wellness center for combat veterans and first responders. Since then, Boulder Crest has become the home of Posttraumatic Growth, pioneering research-backed training programs that enable combat veterans and first responders to live great lives in the aftermath of trauma.” said Ken Falke, Chair & Founder, Boulder Crest Foundation.

Boulder Crest Foundation is transforming our country’s approach to mental health using the science of Posttraumatic Growth – the idea that you can thrive, not just survive, in the aftermath of trauma.

Boulder Crest’s pioneering programs focus on both prevention and intervention. These programs —Warrior PATHH, Struggle Well training, Struggle Well Experience, and Family R&R— help participants and their families transform struggle and trauma into lifelong growth and strength.

To date, the nonprofit has impacted over 100,000 active-duty military, veterans, first responders, and their family members – those on the front lines who serve us all.

To learn more about Boulder Crest Foundation, apply to programs or donate, go to bouldercrest.org. Watch Boulder Crest’s latest short film, Reborn.

About Boulder Crest Foundation

Boulder Crest Foundation, the home of Posttraumatic Growth (PTG), is the global leader in the development, delivery, study, and scale of PTG-based programs. Boulder Crest is a nationally recognized 501(c)(3) nonprofit focused on ensuring the military, veteran, and first responder communities can live great lives in the aftermath of trauma. Suicide claims the lives of over 20 veterans every day, and more first responders die annually by suicide than in the line of fire. It is estimated that 30-40% of our nation’s first responders are struggling with significant mental health challenges. The need is great – traditional approaches to mental health are not working for these communities and a new and innovative approach is desperately required. Boulder Crest is pioneering training programs based on the science of PTG. These evidence-based programs — offered at no cost to participants — train members of the military, veterans, and first responders to experience PTG and thrive in the aftermath of traumatic events.

Boulder Crest’s flagship PTG programs are called: Warrior PATHH (Progressive and Alternative Training for Helping Heroes), Struggle Well and the Struggle Well Experience. These programs are delivered at Boulder Crest’s beautiful facilities in Bluemont, Virginia and Sonoita, Arizona, across the nation through our two Warrior PATHH Mobile Training Teams and Struggle Well trainers, and in partnership with seven other nonprofit organizations, located in Arkansas, Florida, Georgia, Maine, South Carolina, Texas, and Washington State. In total, Boulder Crest’s PTG-based programs have been delivered in 21 states.

Since its founding in 2010, Boulder Crest consistently demonstrates a history of disruptive innovation. Boulder Crest is transforming society’s perception of mental health, trauma, and growth, by building the first, privately-funded wellness center for combat veterans and their families in 2013; creating the first-ever program based on the science of PTG in 2014 with Warrior PATHH; creating the first PTG-based think tank in 2018 with the Boulder Crest Institute for Posttraumatic Growth; establishing the first PTG-based network with the Avalon Action Alliance in 2019; and bringing PTG into the world of first responders for the first time in 2021 with Struggle Well training. Learn more at bouldercrest.org and connect on Facebook, Instagram, LinkedIn and YouTube.

Media Contact

Nubia DuVall Wilson, Boulder Crest Foundation, 1 16463570428, [email protected], www.bouldercrest.org

SOURCE Boulder Crest Foundation



Science: Biology

Merlot Marketing promotes Chad Riley to Director of Client Services

Leave a comment


Click to Tweet: Nationally recognized marketing and PR agency, @MerlotMarketing, has promoted Chad Riley to Director of Client Services. Riley will oversee and lead the strategic direction and efforts of all client relationships at the agency. https://merlotmarketing.com

Since starting in 2014, Riley has demonstrated strong leadership capabilities and a keen understanding in creating and sustaining client relationships. While overseeing marketing initiatives and driving strategy for key clients at Merlot, Riley has also ensured that the latest tools and platforms are utilized across the agency to achieve optimized results. Additionally, Riley has elevated Merlot’s PR.0™ program and is integral in providing client support at national trade shows like the Kitchen and Bath Industry Show (KBIS), and the International Builders’ Show (IBS).

“Chad has played a pivotal role in the agency’s significant journey of growth and success,” stated Debi Hammond, Founder and CEO of Merlot Marketing. “This well-deserved promotion stands as a testament to his dedication, exceptional talent, and invaluable contributions to both our clients and our team. I am excited to see him continue to grow and excel in this new leadership role.”

Riley holds a Bachelor of Arts in Communications and Media Studies from DePauw University and currently resides in Nashville, Tennessee with his wife of over four years, and their infant son. Apart from work, Riley spends his time traveling, swimming, learning about history and enjoying Marvel comics and films.

Learn more about Riley’s new role, his previous professional experience that has led to his impressive success at Merlot, and his insights on the marketing, public relations and agency world on his LinkedIn.

About Merlot Marketing
Celebrating 22 years of articulating and sharing brand stories, Merlot Marketing is an award-winning, national marketing agency that focuses on public relations (PR.0™), brand strategy, social media, advertising and digital communications. Headquartered in California, with satellite offices located across the country, Merlot promotes brands throughout North America and Canada. The agency specializes in the home and building products category and has helped numerous companies articulate their brand position and purpose through its proprietary REDiscover™ Process and then promotes it through PR.0. In 2022, Merlot Marketing was named Influential Agency of the Year by the Public Relations Society of America (PRSA) and is a proud member of the National Kitchen & Bath Association (NKBA). With Heart & Hustle, the agency empowers challenger brands to thrive. Discover Merlot Marketing’s passion, creativity and results at http://www.merlotmarketing.com.

Media Contact

Jessica Sepic, Merlot Marketing, Inc., (916) 285-9835, [email protected], https://merlotmarketing.com 

SOURCE Merlot Marketing, Inc.

Health

Le groupe Besins Healthcare inaugure sa nouvelle usine de production d'hormones à Muel, en Espagne et vise à augmenter de 30 % ses capacités de production mondiales.

Leave a comment



Besins Healthcare inaugure une nouvelle usine en Europe afin de répondre à la croissance de la demande mondiale en hormones et de contribuer à la souveraineté européenne dans la production de médicaments hormonaux. MONACO, 26 septembre 2023 /PRNewswire/ — Besins Healthcare, un des…